Therapeutic angiogenesis: controlled delivery of angiogenic factors.
about
Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical PracticeDrug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsDepot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewExtracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineImproved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting MoleculesAngiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart DiseasePositive selection for bone morphogenetic protein receptor type-IB promotes differentiation and specification of human adipose-derived stromal cells toward an osteogenic lineage.Integration of drug, protein, and gene delivery systems with regenerative medicine.Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.Collaterals: Implications in cerebral ischemic diseases and therapeutic interventionsControlled dual delivery of fibroblast growth factor-2 and Interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair.ASC spheroid geometry and culture oxygenation differentially impact induction of preangiogenic behaviors in endothelial cells.Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease.VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies.Angiogenic potency evaluation of cell therapy candidates by a novel application of the in vitro aortic ring assay.Dual delivery of vascular endothelial growth factor and hepatocyte growth factor coacervate displays strong angiogenic effects.Alginate for cardiac regeneration: From seaweed to clinical trials.HSPA12B and repairing the heart: beauty in simplicity.Tunable delayed controlled release profile from layered polymeric microparticles.Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration.The effect of heparinized decellularized scaffolds on angiogenic capability.Controlled release of a heterogeneous human placental matrix from PLGA microparticles to modulate angiogenesis.The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro.Integration of induced pluripotent stem cell-derived endothelial cells with polycaprolactone/gelatin-based electrospun scaffolds for enhanced therapeutic angiogenesis.Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling.A short discourse on vascular tissue engineering.Therapeutic neovascularization promoted by injectable hydrogels.
P2860
Q26744494-4CA39F56-BD81-429F-90D8-76EEC709C87FQ26798467-9F17268E-0CD2-4DC7-B6F8-49961152BAFFQ26799856-787B74C2-B7D9-4D9D-8BB3-5EB161EC1101Q26829783-F3164440-E19F-4A73-8AB9-F281133A9E1EQ27303518-D60444E5-46A4-453D-8925-1D6CFDE5CAE0Q27340828-729D12DB-32F8-4B24-BEFD-9914FD358092Q34499963-E28646A0-FE6E-4670-BC2C-8D94096A999EQ35241569-410CDEE5-40FA-4BAC-AE3D-C5F36ADCD61FQ35602789-B4677286-A08C-46C8-A4D2-05E432FAA72AQ36053227-E0478264-85E0-4144-BF83-DB921832F6F4Q36198993-F7EEA0B9-194B-4970-A1FC-DCC7905331A2Q36771710-C42933A9-6455-45CD-A378-86EE1666C2CBQ37262654-EFF7FBE3-BD64-4D30-8ACE-DCDF5A7DC93BQ38841567-7095457C-A2DC-48F8-B1F7-D08CC946248BQ39378135-4A65C393-027F-4F93-BB32-156F100E5E08Q39401943-0567F3C2-CAEE-47DE-8345-1CA9F93816B7Q41413714-5504AB47-820A-462A-B101-D028FB7E10B7Q41891314-D7134631-A385-4970-BD10-352EE7D73BADQ42378618-9687044B-C8DB-49BD-B7ED-D07DA1EEE4C5Q42559907-77EA0F71-A761-429D-954C-03C6B0706618Q47983722-DF646D5B-16CB-4F6D-9738-D96716BFF6E0Q51022833-8553B66C-3BFF-4741-A1EA-1617CB36BBD8Q51122138-3EEE771C-314D-4CF9-8695-7F204F7F8C91Q51529527-E514EAFE-3C7C-4094-96E2-DC4F5EDB5339Q52469415-DFCAEB9F-5DE6-468D-9C2E-29C717416C81Q52644323-D5205C42-B992-489C-8A5F-D5072F66D7F6Q52691581-F2C3AAB9-01DB-421A-BC24-EEDAFBD1D126Q52924173-90AD758C-3E13-4288-9BB6-140964731775Q55638524-BED5EB33-6A6B-4157-B9B4-F22BE163C38D
P2860
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic angiogenesis: controlled delivery of angiogenic factors
@nl
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@ast
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@en
type
label
Therapeutic angiogenesis: controlled delivery of angiogenic factors
@nl
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@ast
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@en
prefLabel
Therapeutic angiogenesis: controlled delivery of angiogenic factors
@nl
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@ast
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@en
P2860
P3181
P356
P1433
P1476
Therapeutic angiogenesis: controlled delivery of angiogenic factors.
@en
P2093
Hunghao Chu
Yadong Wang
P2860
P304
P3181
P356
10.4155/TDE.12.50
P407
P577
2012-06-01T00:00:00Z